Quarterly report · Q3
7745.TEDINET S100SUG2
Period2023-04-01 → 2023-12-31
Filed2024-02-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 36
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥44.5bn | 2023-04-01 → 2023-12-31 | Cons. | Net sales |
| Revenue | ¥59.0bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥42.2bn | 2022-04-01 → 2022-12-31 | Cons. | Net sales |
| Operating income | ¥5.2bn | 2023-04-01 → 2023-12-31 | Cons. | Operating income |
| Operating income | ¥4.7bn | 2022-04-01 → 2022-12-31 | Cons. | Operating income |
| Ordinary income | ¥5.3bn | 2023-04-01 → 2023-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥7.6bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥4.9bn | 2022-04-01 → 2022-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥5.3bn | 2023-04-01 → 2023-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥4.9bn | 2022-04-01 → 2022-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥3.6bn | 2023-04-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥5.5bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥3.5bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥3.6bn | 2023-04-01 → 2023-12-31 | Cons. | Profit loss |
| Net income | ¥3.5bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss |
| Total assets | ¥69.5bn | at 2023-12-31 | Cons. | Assets |
| Total assets | ¥69.4bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥68.1bn | at 2022-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥34.1bn | at 2023-12-31 | Cons. | Liabilities |
| Total liabilities | ¥36.8bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥35.4bn | at 2023-12-31 | Cons. | Net assets |
| Net assets / equity | ¥32.6bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥30.9bn | at 2022-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥15.0bn | at 2023-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥15.0bn | at 2023-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥132.3 | 2023-04-01 → 2023-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥53.99 | 2023-10-01 → 2023-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥201.33 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥128.43 | 2022-04-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥74.97 | 2022-10-01 → 2022-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥132.17 | 2023-04-01 → 2023-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥201.14 | 2022-04-01 → 2023-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥128.31 | 2022-04-01 → 2022-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 50.8% | at 2023-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 46.8% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 45.2% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 97
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-12-31 | −¥18.8bn |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-12-31 | −¥18.8bn |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-12-31 | −¥1.7bn |
| jpcrp040300-q3r_E02344-000America Measuring Instrumentsreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥3.3bn |
| jpcrp040300-q3r_E02344-000America Measuring Instrumentsreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥3.1bn |
| jpcrp040300-q3r_E02344-000America Measuring Instrumentsreportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥266m |
| jpcrp040300-q3r_E02344-000America Measuring Instrumentsreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥107m |
| jpcrp040300-q3r_E02344-000America Medical And Health Systemreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥7.1bn |
| jpcrp040300-q3r_E02344-000America Medical And Health Systemreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥7.1bn |
| jpcrp040300-q3r_E02344-000America Medical And Health Systemreportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥0 |
| jpcrp040300-q3r_E02344-000America Medical And Health Systemreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥427m |
| jpcrp040300-q3r_E02344-000Asia And Oceania Measuring Instrumentsreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥5.7bn |
| jpcrp040300-q3r_E02344-000Asia And Oceania Measuring Instrumentsreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥3.7bn |
| jpcrp040300-q3r_E02344-000Asia And Oceania Measuring Instrumentsreportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥1.9bn |
| jpcrp040300-q3r_E02344-000Asia And Oceania Measuring Instrumentsreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥292m |
| jpcrp040300-q3r_E02344-000Asia And Oceania Medical And Health Systemreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥6.3bn |
| jpcrp040300-q3r_E02344-000Asia And Oceania Medical And Health Systemreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥288m |
| jpcrp040300-q3r_E02344-000Asia And Oceania Medical And Health Systemreportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥6.1bn |
| jpcrp040300-q3r_E02344-000Asia And Oceania Medical And Health Systemreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥306m |
| jpcrp040300-q3r_E02344-000Europe Measuring Instrumentsreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥452m |
| jpcrp040300-q3r_E02344-000Europe Measuring Instrumentsreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥452m |
| jpcrp040300-q3r_E02344-000Europe Measuring Instrumentsreportable segment | segment profit | 2023-04-01 → 2023-12-31 | −¥36m |
| jpcrp040300-q3r_E02344-000Europe Medical And Health Systemreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥5.9bn |
| jpcrp040300-q3r_E02344-000Europe Medical And Health Systemreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥5.9bn |
| jpcrp040300-q3r_E02344-000Europe Medical And Health Systemreportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥11m |
| jpcrp040300-q3r_E02344-000Europe Medical And Health Systemreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥358m |
| jpcrp040300-q3r_E02344-000Japan Measuring Instrumentsreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥14.2bn |
| jpcrp040300-q3r_E02344-000Japan Measuring Instrumentsreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥12.2bn |
| jpcrp040300-q3r_E02344-000Japan Measuring Instrumentsreportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥2.0bn |
| jpcrp040300-q3r_E02344-000Japan Measuring Instrumentsreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥490m |
| jpcrp040300-q3r_E02344-000Japan Medical And Health Systemreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥12.4bn |
| jpcrp040300-q3r_E02344-000Japan Medical And Health Systemreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥3.9bn |
| jpcrp040300-q3r_E02344-000Japan Medical And Health Systemreportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥8.6bn |
| jpcrp040300-q3r_E02344-000Japan Medical And Health Systemreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥2.1bn |
| jpcrp040300-q3r_E02344-000Japan Semiconductor Relatedreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥7.8bn |
| jpcrp040300-q3r_E02344-000Japan Semiconductor Relatedreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥7.8bn |
| jpcrp040300-q3r_E02344-000Japan Semiconductor Relatedreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥2.8bn |
| jpcrp040300-q3r_E02344-000Measuring Instrumentsreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥23.6bn |
| jpcrp040300-q3r_E02344-000Measuring Instrumentsreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥19.5bn |
| jpcrp040300-q3r_E02344-000Measuring Instrumentsreportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥4.2bn |
| jpcrp040300-q3r_E02344-000Measuring Instrumentsreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥854m |
| jpcrp040300-q3r_E02344-000Medical And Health Systemreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥31.8bn |
| jpcrp040300-q3r_E02344-000Medical And Health Systemreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥17.2bn |
| jpcrp040300-q3r_E02344-000Medical And Health Systemreportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥14.6bn |
| jpcrp040300-q3r_E02344-000Medical And Health Systemreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥3.2bn |
| jpcrp040300-q3r_E02344-000Semiconductor Related Businessreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥7.8bn |
| jpcrp040300-q3r_E02344-000Semiconductor Related Businessreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥7.8bn |
| jpcrp040300-q3r_E02344-000Semiconductor Related Businessreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥2.8bn |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-12-31 | −¥21.8bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-12-31 | −¥21.8bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-12-31 | −¥1.9bn |
| jpcrp040300-q3r_E02344-000America Measuring Instrumentsreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥4.7bn |
| jpcrp040300-q3r_E02344-000America Measuring Instrumentsreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥4.4bn |
| jpcrp040300-q3r_E02344-000America Measuring Instrumentsreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥352m |
| jpcrp040300-q3r_E02344-000America Measuring Instrumentsreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥486m |
| jpcrp040300-q3r_E02344-000America Medical And Health Systemreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥6.8bn |
| jpcrp040300-q3r_E02344-000America Medical And Health Systemreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥6.8bn |
| jpcrp040300-q3r_E02344-000America Medical And Health Systemreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥1m |
| jpcrp040300-q3r_E02344-000America Medical And Health Systemreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥31m |
| jpcrp040300-q3r_E02344-000Asia And Oceania Measuring Instrumentsreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥6.3bn |
| jpcrp040300-q3r_E02344-000Asia And Oceania Measuring Instrumentsreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥3.8bn |
| jpcrp040300-q3r_E02344-000Asia And Oceania Measuring Instrumentsreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥2.5bn |
| jpcrp040300-q3r_E02344-000Asia And Oceania Measuring Instrumentsreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥451m |
| jpcrp040300-q3r_E02344-000Asia And Oceania Medical And Health Systemreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥7.4bn |
| jpcrp040300-q3r_E02344-000Asia And Oceania Medical And Health Systemreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥328m |
| jpcrp040300-q3r_E02344-000Asia And Oceania Medical And Health Systemreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥7.0bn |
| jpcrp040300-q3r_E02344-000Asia And Oceania Medical And Health Systemreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥242m |
| jpcrp040300-q3r_E02344-000Europe Measuring Instrumentsreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥730m |
| jpcrp040300-q3r_E02344-000Europe Measuring Instrumentsreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥729m |
| jpcrp040300-q3r_E02344-000Europe Measuring Instrumentsreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥0 |
| jpcrp040300-q3r_E02344-000Europe Measuring Instrumentsreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥102m |
| jpcrp040300-q3r_E02344-000Europe Medical And Health Systemreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥7.2bn |
| jpcrp040300-q3r_E02344-000Europe Medical And Health Systemreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥7.2bn |
| jpcrp040300-q3r_E02344-000Europe Medical And Health Systemreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥3m |
| jpcrp040300-q3r_E02344-000Europe Medical And Health Systemreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥1.2bn |
| jpcrp040300-q3r_E02344-000Japan Measuring Instrumentsreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥13.8bn |
| jpcrp040300-q3r_E02344-000Japan Measuring Instrumentsreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥11.0bn |
| jpcrp040300-q3r_E02344-000Japan Measuring Instrumentsreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥2.9bn |
| jpcrp040300-q3r_E02344-000Japan Measuring Instrumentsreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥541m |
| jpcrp040300-q3r_E02344-000Japan Medical And Health Systemreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥13.1bn |
| jpcrp040300-q3r_E02344-000Japan Medical And Health Systemreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥4.1bn |
| jpcrp040300-q3r_E02344-000Japan Medical And Health Systemreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥9.0bn |
| jpcrp040300-q3r_E02344-000Japan Medical And Health Systemreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥2.3bn |
| jpcrp040300-q3r_E02344-000Japan Semiconductor Relatedreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥4.0bn |
| jpcrp040300-q3r_E02344-000Japan Semiconductor Relatedreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥4.0bn |
| jpcrp040300-q3r_E02344-000Japan Semiconductor Relatedreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥1.3bn |
| jpcrp040300-q3r_E02344-000Measuring Instrumentsreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥25.6bn |
| jpcrp040300-q3r_E02344-000Measuring Instrumentsreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥19.9bn |
| jpcrp040300-q3r_E02344-000Measuring Instrumentsreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥5.8bn |
| jpcrp040300-q3r_E02344-000Measuring Instrumentsreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥1.6bn |
| jpcrp040300-q3r_E02344-000Medical And Health Systemreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥34.5bn |
| jpcrp040300-q3r_E02344-000Medical And Health Systemreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥18.4bn |
| jpcrp040300-q3r_E02344-000Medical And Health Systemreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥16.1bn |
| jpcrp040300-q3r_E02344-000Medical And Health Systemreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥3.8bn |
| jpcrp040300-q3r_E02344-000Semiconductor Related Businessreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥4.0bn |
| jpcrp040300-q3r_E02344-000Semiconductor Related Businessreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥4.0bn |
| jpcrp040300-q3r_E02344-000Semiconductor Related Businessreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥1.3bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 449
| Item | Context | Value | Unit |
|---|---|---|---|
| Business risks (text) | FilingDateInstant | Text · Plus | |
| Management analysis of financial position operating results and cash flows (text) | FilingDateInstant | Text · Plus | |
| Critical contracts for operation (text) | FilingDateInstant | Text · Plus | |
| Total number of shares (text) | FilingDateInstant | Text · Plus | |
| Issued shares total number of shares etc (text) | FilingDateInstant | Text · Plus | |
| Class issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)普通株式 | |
| Name of financial instruments exchange on which securities are listed or authorized financial instruments business association to which securities are registered | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)東京証券取引所プライム市場 | |
| Description issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)単元株式数100株 | |
| Details of employee share option program (text) | FilingDateInstant | Text · Plus | |
| Other information on share acquisition rights (text) | FilingDateInstant | Text · Plus | |
| Exercises etc of moving strike convertible bonds etc (text) | FilingDateInstant | Text · Plus | |
| Changes in number of issued shares stated capital etc (text) | FilingDateInstant | Text · Plus | |
| Major shareholders (text) | FilingDateInstant | Text · Plus | |
| Voting rights (text) | FilingDateInstant | Text · Plus | |
| Issued shares voting rights (text) | FilingDateInstant | Text · Plus | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | － | |
| Treasury shares etc (text) | FilingDateInstant | Text · Plus | |
| Name of shareholder treasury shares etc | CurrentQuarterInstant_Row1Member | Original text (Japanese)株式会社Ａ＆Ｄホロンホールディングス | |
| Address of shareholder treasury shares etc | CurrentQuarterInstant_Row1Member | Original text (Japanese)東京都豊島区東池袋三丁目23番14号 | |
| Information about officers (text) | FilingDateInstant | Text · Plus | |
| Regulations in accordance with which consolidated financial statements have been prepared financial information | CurrentYTDDuration | Text · Plus | |
| Note on independent audit financial information | CurrentYTDDuration | Text · Plus | |
| Quarterly consolidated balance sheet (text) | CurrentYTDDuration | Text · Plus | |
| Year to quarter end consolidated statement of income (text) | CurrentYTDDuration | Text · Plus | |
| Year to quarter end consolidated statement of comprehensive income (text) | CurrentYTDDuration | Text · Plus | |
| Notes changes in accounting policies in accordance with changes in accounting standards etc quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes accounting treatments specific to quarterly financial statements quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes regarding allowances directly deducted from balances of assets (text) | CurrentQuarterInstant | Text · Plus | |
| Notes regarding promissory notes due on balance sheet date (text) | CurrentQuarterInstant | Text · Plus | |
| Notes regarding financial covenants (text) | CurrentQuarterInstant | Text · Plus | |
| Description of fact that quarterly statement of cash flows has not been prepared (text) | CurrentYTDDuration | Text · Plus | |
| Notes regarding dividend (text) | Prior1YTDDuration | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | Prior1YTDDuration | Text · Plus | |
| Notes regarding dividend (text) | CurrentYTDDuration | Text · Plus | |
| Notes segment information etc quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | Prior1YTDDuration | Text · Plus | |
| Information about impairment loss of non current assets or goodwill etc for each reportable segment (text) | Prior1YTDDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | CurrentYTDDuration | Text · Plus | |
| Information about impairment loss of non current assets or goodwill etc for each reportable segment (text) | CurrentYTDDuration | Text · Plus | |
| Notes revenue recognition quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes per share information quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes significant events after reporting period quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | CurrentYTDDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |